# A Study to Assess the Safety, Tolerability and Pharmacokinetics of Multiple Subcutaneous Injections of ABBV-257 in Subjects With Rheumatoid Arthritis

> **NCT02531178** · PHASE1 · COMPLETED · sponsor: **AbbVie** · enrollment: 8 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **BIOLOGICAL:** ABBV-257
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT02531178
- **Lead sponsor:** AbbVie
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-07
- **Primary completion:** 2016-02
- **Final completion:** 2016-02
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2016-03-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02531178

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02531178, "A Study to Assess the Safety, Tolerability and Pharmacokinetics of Multiple Subcutaneous Injections of ABBV-257 in Subjects With Rheumatoid Arthritis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02531178. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*